SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently trading higher as investors react to strong institutional accumulation, a high-profile Nasdaq debut of a key memory supplier, and reports of conditional export approvals for H200 chips in China. The market sentiment is heavily focused on the company's role as the foundation of AI infrastructure, with traders debating whether this momentum represents a sustainable breakout above recent resistance levels or a potential squeeze ahead of upcoming earnings.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is trending following its major US listing, sparking intense debate among investors over its long-term potential as a key memory supplier for AI infrastructure versus concerns about potential IPO-style volatility. Community members are actively comparing its HBM market dominance and valuation metrics against established domestic semiconductor leaders while debating whether the influx of liquidity will trigger a broader sector rotation or simply validate the ongoing memory supercycle.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF is experiencing heightened volatility as investors weigh robust underlying demand for AI memory against significant technical selling pressure and a complex global rebalancing ahead of a major industry ADR listing. While the community remains divided between those capitalizing on the dip as a long-term value opportunity and others concerned by recent downward price action, conversation is heavily focused on how foreign listing mechanics and institutional positioning are driving current market movements.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as traders debate the market's resilience against persistent geopolitical tensions in the Middle East and concerns over slowing AI capital expenditure. The community remains sharply divided between bulls banking on continued rotation into growth tech and bears expecting a broader market correction driven by high valuations and geopolitical instability.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh the stock's long-term growth potential in LNG exports against ongoing geopolitical volatility in the Strait of Hormuz. The community is actively debating the company's valuation relative to its aggressive production targets, with many focusing on the impact of regional conflict on supply chains versus the fundamental tailwinds of global energy demand.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility and intense community debate as market participants weigh renewed geopolitical tensions in the Strait of Hormuz against upcoming earnings reports and economic data. Investors remain divided, with many actively monitoring futures for direction while debating whether the market's recent resilience signifies a true bull trend or a vulnerable position prone to a sharp reversal.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is trending as traders analyze aggressive institutional accumulation in biotech and the sector's breakout potential following significant M&A activity. Community discussion is focused on the impact of shifting rate expectations, institutional inflows into related ETFs, and the technical setup as the biotech sector tests key resistance levels amid broader market rotation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant community debate as investors weigh the company's long-term potential in AI infrastructure and power capacity against concerns over founder compensation and ongoing share dilution. While some traders are closely watching critical support levels and technical chart setups for a potential recovery, sentiment remains divided between those capitalizing on dip-buying opportunities and those skeptical of management's recent capital allocation decisions.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as investors navigate aggressive rebalancing by the Korean National Pension Service and a broader unwind of crowded semiconductor trades. Community discussion is sharply divided between those viewing the pullback as a technical entry opportunity ahead of upcoming domestic IPOs and those bracing for further downside from leveraged position liquidations.

ETF Opportunities Trust - Roundhill T-REX 2X Long DRAM Daily Target ETF

T-REX 2X Long DRAM Daily Target ETF

RAM is experiencing significant trading activity following its recent debut as a leveraged 2X bull ETF designed to track the DRAM memory sector, capturing the immediate momentum from strong earnings in the semiconductor space. The community is actively debating the product's high-beta risk and volatility, with participants polarized between those betting on an extended AI memory supercycle and others warning of the dangers inherent in holding leveraged instruments during sector pullbacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026

Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026...

Taysha Gene Therapies (NASDAQ:TSHA) Issues Earnings Results

Taysha Gene Therapies (NASDAQ:TSHA - Get Free Report) released its earnings results on Wednesday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.02...

Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month High  - Here's What Happened

Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - What's Next...

Taysha Gene Therapies (TSHA) to Release Earnings on Wednesday

Taysha Gene Therapies (NASDAQ:TSHA) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-taysha-gene-therapies-inc-stock...

Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month High  - Should You Buy?

Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - Here's What Happened...

Taysha Gene Therapies Sees Unusually High Options Volume (NASDAQ:TSHA)

Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) was the target of some unusual options trading on Thursday. Stock investors acquired 6,277 call options on the company. This is an increase...

Taysha Gene Therapies (NASDAQ:TSHA) Sets New 12-Month High  - Still a Buy?

Taysha Gene Therapies (NASDAQ:TSHA) Hits New 52-Week High - What's Next...

Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 9% - Should You Buy?

Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 9% - Still a Buy...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of "Buy" by Brokerages

Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has received an average rating of "Buy" from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities...

Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells $892,000.00 in Stock

Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the business's stock in a transaction dated Friday, April 10th. The shares were sold at an...

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.

Taysha Gene Therapies Inc

Taysha Gene Therapies Stock Soars To 3-Year High After FDA Boost — Wall Street Calls Rett Drug ‘Derisked’ And Ahead Of Rivals

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$6.34
Prev Close	$6.57
Open	$6.52
Dividend Yield	0.00%
50-Day Moving Average	$6.17
Beta	1.68
Avg. Volume	3.82M
PE Ratio	-16.00

52-Week High	$7.30
52-Week Low	$2.34
Market Capitalization	$2.06B
EPS (Annual)	-$0.3409
Price to Book	8.59
Revenue Per Employee	$98,717.17

Feed

News

Sentiment

Earnings

Fundamentals

Info

TSHATaysha Gene Therapies Inc

Latest TSHA News